secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0000950170-24-014534
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences announces 1-for-12 reverse stock split effective Feb 9, 2024 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-12 ratio effective Feb 9, 2024; trading begins split-adjusted Feb 12 under same symbol ASMB.
- Shares outstanding reduced from ~65.8M to ~5.5M; fractional shares paid in cash based on Feb 8 closing price.
- Primary purpose is to meet Nasdaq minimum bid price requirement for continued listing.
- Stockholders approved reverse split range at Jan 31 special meeting; Board selected 1-for-12 ratio on Jan 31.
- New CUSIP 045396207; Equiniti Trust Company acts as exchange agent; proportionate adjustments to equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000095017024014534/0000950170-24-014534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000095017024014534/asmb-20240208.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-014534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer